Latest News

Emmaus withdraws European application for sickle cell drug that got US approval

The company said it would withdraw the application for Xyndari after the EMA’s Committee for Medicinal Products for Human Use followed a negative opinion from May. The FDA approved the drug under the brand name Endari in 2017.

Source link

Related posts

Blood Test for Pancreatic Cancer May Aid Detection


Medtech isn’t spending enough on R&D, report says


Secondhand pot smoke found in kids' lungs


This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy